Cargando…
Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose
BACKGROUND: Diabetes is a risk factor for respiratory infection, and hyperglycaemia is associated with increased glucose in airway surface liquid and risk of Staphylococcus aureus infection. OBJECTIVES: To investigate whether elevation of basolateral/blood glucose concentration promotes airway Staph...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756442/ https://www.ncbi.nlm.nih.gov/pubmed/23709760 http://dx.doi.org/10.1136/thoraxjnl-2012-203178 |
_version_ | 1782282098740035584 |
---|---|
author | Garnett, James P Baker, Emma H Naik, Sonam Lindsay, Jodi A Knight, Gwenan M Gill, Simren Tregoning, John S Baines, Deborah L |
author_facet | Garnett, James P Baker, Emma H Naik, Sonam Lindsay, Jodi A Knight, Gwenan M Gill, Simren Tregoning, John S Baines, Deborah L |
author_sort | Garnett, James P |
collection | PubMed |
description | BACKGROUND: Diabetes is a risk factor for respiratory infection, and hyperglycaemia is associated with increased glucose in airway surface liquid and risk of Staphylococcus aureus infection. OBJECTIVES: To investigate whether elevation of basolateral/blood glucose concentration promotes airway Staphylococcus aureus growth and whether pretreatment with the antidiabetic drug metformin affects this relationship. METHODS: Human airway epithelial cells grown at air–liquid interface (±18 h pre-treatment, 30 μM–1 mM metformin) were inoculated with 5×10(5) colony-forming units (CFU)/cm(2) S aureus 8325-4 or JE2 or Pseudomonas aeruginosa PA01 on the apical surface and incubated for 7 h. Wild-type C57BL/6 or db/db (leptin receptor-deficient) mice, 6–10 weeks old, were treated with intraperitoneal phosphate-buffered saline or 40 mg/kg metformin for 2 days before intranasal inoculation with 1×10(7) CFU S aureus. Mice were culled 24 h after infection and bronchoalveolar lavage fluid collected. RESULTS: Apical S aureus growth increased with basolateral glucose concentration in an in vitro airway epithelia–bacteria co-culture model. S aureus reduced transepithelial electrical resistance (R(T)) and increased paracellular glucose flux. Metformin inhibited the glucose-induced growth of S aureus, increased R(T) and decreased glucose flux. Diabetic (db/db) mice infected with S aureus exhibited a higher bacterial load in their airways than control mice after 2 days and metformin treatment reversed this effect. Metformin did not decrease blood glucose but reduced paracellular flux across ex vivo murine tracheas. CONCLUSIONS: Hyperglycaemia promotes respiratory S aureus infection, and metformin modifies glucose flux across the airway epithelium to limit hyperglycaemia-induced bacterial growth. Metformin might, therefore, be of additional benefit in the prevention and treatment of respiratory infection. |
format | Online Article Text |
id | pubmed-3756442 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-37564422013-08-30 Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose Garnett, James P Baker, Emma H Naik, Sonam Lindsay, Jodi A Knight, Gwenan M Gill, Simren Tregoning, John S Baines, Deborah L Thorax Respiratory Infection BACKGROUND: Diabetes is a risk factor for respiratory infection, and hyperglycaemia is associated with increased glucose in airway surface liquid and risk of Staphylococcus aureus infection. OBJECTIVES: To investigate whether elevation of basolateral/blood glucose concentration promotes airway Staphylococcus aureus growth and whether pretreatment with the antidiabetic drug metformin affects this relationship. METHODS: Human airway epithelial cells grown at air–liquid interface (±18 h pre-treatment, 30 μM–1 mM metformin) were inoculated with 5×10(5) colony-forming units (CFU)/cm(2) S aureus 8325-4 or JE2 or Pseudomonas aeruginosa PA01 on the apical surface and incubated for 7 h. Wild-type C57BL/6 or db/db (leptin receptor-deficient) mice, 6–10 weeks old, were treated with intraperitoneal phosphate-buffered saline or 40 mg/kg metformin for 2 days before intranasal inoculation with 1×10(7) CFU S aureus. Mice were culled 24 h after infection and bronchoalveolar lavage fluid collected. RESULTS: Apical S aureus growth increased with basolateral glucose concentration in an in vitro airway epithelia–bacteria co-culture model. S aureus reduced transepithelial electrical resistance (R(T)) and increased paracellular glucose flux. Metformin inhibited the glucose-induced growth of S aureus, increased R(T) and decreased glucose flux. Diabetic (db/db) mice infected with S aureus exhibited a higher bacterial load in their airways than control mice after 2 days and metformin treatment reversed this effect. Metformin did not decrease blood glucose but reduced paracellular flux across ex vivo murine tracheas. CONCLUSIONS: Hyperglycaemia promotes respiratory S aureus infection, and metformin modifies glucose flux across the airway epithelium to limit hyperglycaemia-induced bacterial growth. Metformin might, therefore, be of additional benefit in the prevention and treatment of respiratory infection. BMJ Publishing Group 2013-09 2013-05-24 /pmc/articles/PMC3756442/ /pubmed/23709760 http://dx.doi.org/10.1136/thoraxjnl-2012-203178 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/ |
spellingShingle | Respiratory Infection Garnett, James P Baker, Emma H Naik, Sonam Lindsay, Jodi A Knight, Gwenan M Gill, Simren Tregoning, John S Baines, Deborah L Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose |
title | Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose |
title_full | Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose |
title_fullStr | Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose |
title_full_unstemmed | Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose |
title_short | Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose |
title_sort | metformin reduces airway glucose permeability and hyperglycaemia-induced staphylococcus aureus load independently of effects on blood glucose |
topic | Respiratory Infection |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756442/ https://www.ncbi.nlm.nih.gov/pubmed/23709760 http://dx.doi.org/10.1136/thoraxjnl-2012-203178 |
work_keys_str_mv | AT garnettjamesp metforminreducesairwayglucosepermeabilityandhyperglycaemiainducedstaphylococcusaureusloadindependentlyofeffectsonbloodglucose AT bakeremmah metforminreducesairwayglucosepermeabilityandhyperglycaemiainducedstaphylococcusaureusloadindependentlyofeffectsonbloodglucose AT naiksonam metforminreducesairwayglucosepermeabilityandhyperglycaemiainducedstaphylococcusaureusloadindependentlyofeffectsonbloodglucose AT lindsayjodia metforminreducesairwayglucosepermeabilityandhyperglycaemiainducedstaphylococcusaureusloadindependentlyofeffectsonbloodglucose AT knightgwenanm metforminreducesairwayglucosepermeabilityandhyperglycaemiainducedstaphylococcusaureusloadindependentlyofeffectsonbloodglucose AT gillsimren metforminreducesairwayglucosepermeabilityandhyperglycaemiainducedstaphylococcusaureusloadindependentlyofeffectsonbloodglucose AT tregoningjohns metforminreducesairwayglucosepermeabilityandhyperglycaemiainducedstaphylococcusaureusloadindependentlyofeffectsonbloodglucose AT bainesdeborahl metforminreducesairwayglucosepermeabilityandhyperglycaemiainducedstaphylococcusaureusloadindependentlyofeffectsonbloodglucose |